Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIMINATE trial
2023-505361-86-00Phase 4Authorised
- Sponsor
- Region Örebro län
- Start
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) and influenza comparing Influenza vaccine (VaxigripTetra) with Placebo (sodium chloride) (2 arms). Primary endpoint: Change in pericoronary adipose tissue density (right coronary artery). Planned start Nov 2023; status: authorised.
02
Drugs
Vaxigrip
03
Conditions
myocardial infarction (MI)influenza
Beyond the preview
Go deeper on 2023-505361-86-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505361-86-00.